National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 22,193 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1267 out of 2,220

Result pages: prev   1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276   next


VAERS ID: 1200084 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-07
Onset:2021-01-31
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Echocardiogram, Loss of consciousness, Pulmonary embolism, Pulmonary hypertension, Syncope, Thrombosis, Ultrasound scan
SMQs:, Torsade de pointes/QT prolongation (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Pulmonary hypertension (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-16
   Days after onset: 16
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Pleuropneumonia (already been described about 20 years ago); Postphlebitic syndrome (already been described about 20 years ago)
Preexisting Conditions: Medical History/Concurrent Conditions: Bronchitis (from time to time)
Allergies:
Diagnostic Lab Data: Test Date: 20210131; Test Name: echo; Result Unstructured Data: Test Result:pulmonary hypertension; Test Date: 20210131; Test Name: Sonography; Result Unstructured Data: Test Result:in the assessment tab; Comments: lower leg thromboses on both legs, found pulmonary hypertension
CDC Split Type: DEPFIZER INC2021380842

Write-up: Lung embolism/severe pulmonary embolism; syncopated; unconscious for a short time; lower leg thromboses on both legs; Pulmonary hypertension; This is a spontaneous report from a non-contactable consumer downloaded from the Agency Regulatory Authority-WEB, regulatory authority report number is DE-PEI-CADR2021040401. Safety report unique identifier DE-PEI-202100027932. A 100-year-old female patient received BNT162B2 (COMIRNATY), intramuscular , dose 1 on 17Jan2021 (Batch/Lot number was not reported) and dose 2 on 07Feb2021 (Batch/Lot number was not reported) at 0.3 mL (standard dose), single dose, for COVID-19 immunisation. Ongoing medical history included pleuropneumonia and postphlebitic syndrome already been described about 20 years ago, and bronchitis from time to time. The patient had no known allergies. The patient''s concomitant medications were not reported. On 31Jan2021 the patient experienced lung embolism. Further reported that on 31Jan2021, 2 weeks after first vaccination, the patient syncopated, was unconscious for a short time. The hospital found lower leg thromboses on both legs by sonography, found pulmonary hypertension in the echo. From GP''s point of view, this was wrongly seen as a hypertension problem with "primary pulmonary hypertension". The patient died on 16Feb2021, one week after second vaccination on 07Feb2021, under the picture of oppression and shortness of breath and chest pain in 2021 without coagulation-specific medication. The thromboses with pulmonary hypertension are mentioned in the discharge letter, but no one seems to have thought of the actually typical symptoms of a severe pulmonary embolism. The outcome was fatal for lung embolism, recovered for unconscious and unknown for the other events. It was not reported if an autopsy was performed. This report is serious for death. Sender Comment: Do you or the person concerned have any known allergies? If yes, which ones? : no No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Lung embolism/severe pulmonary embolism


VAERS ID: 1200085 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-04
Onset:2021-03-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cerebrovascular accident
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-04
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: DEPFIZER INC2021370494

Write-up: Severe stroke; This is a spontaneous report downloaded from the Agency Regulatory Authority-WEB (Regulatory Authority report number: DE-PEI-CADR2021041088). A non-contactable consumer (contactable through Regulatory Authority only) reported that a 99-year-old female patient received BNT162B2 (COMIRNATY, Lot number and expiration date were not reported), intramuscular on 04Mar2021 as a single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. On 04Mar2021, the patient was diagnosed with severe stroke (described as "sudden paralysis and speech disorder"). The patient had died on 04Mar2021 due to stroke. It was unknown if an autopsy was performed. No follow-up attempts are possible. Batch/lot number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Stroke


VAERS ID: 1200404 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-03
Onset:2021-03-24
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2166 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Death, SARS-CoV-2 test
SMQs:, COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-24
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cognitive impairment; Hypertension arterial; Prostate cancer
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 test; Result Unstructured Data: Test Result:unknown result
CDC Split Type: FRPFIZER INC2021380307

Write-up: Death unexplained; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority -WEB, regulatory authority number FR-AFSSAPS-RN20210986. A 93-year-old male patient received the first dose of BNT162B2 (COMIRNATY, Lot Number: EP2166), intramuscular, administered in left arm on 03Mar2021 as single dose for COVID-19 immunization. Medical history included hypertension, mild cognitive impairment and, prostate cancer from an unknown date. Long-term treatment not reported. No history of allergy was reported. No history of COVID-19 was reported. Concomitant medications were not reported. On 24Mar2021 during the night, unexpected sudden death without prodrome, nocturnal, suggestive of embolism or cardiac accident without further information. Given the time of death and the uncertainty of the diagnosis and age, no examination was carried out and no autopsy was requested. The patient underwent lab tests and procedures which included COVID-19 virus test: unknown results on an unknow date. The patient died on 24Mar2021. An autopsy was not performed. No follow-up attempts is possible. No further information is expected.; Reported Cause(s) of Death: Death unexplained


VAERS ID: 1200422 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH NOT KNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Death, SARS-CoV-2 test
SMQs:, COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Inconclusive test
CDC Split Type: GBPFIZER INC2021382426

Write-up: Death; This is a spontaneous report from a contactable consumer or other non healthcare professional received from the Agency Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202104061126301180. Safety Report Unique Identifier GB-MHRA-ADR 25085543. A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot Number: not known) as single dose for covid-19 immunisation. The patient medical history was not reported. Patient has not had symptoms associated with COVID-19 . Patient is not enrolled in clinical trial. The patient''s concomitant medications were not reported. The patient died o an unknown date. The patient underwent lab tests and procedures which included sars-cov-2 test: inconclusive test. An autopsy was not performed. Patient has not tested positive for COVID-19 since having the vaccine. Patient has not tested positive for COVID-19 since having the vaccine. Follow-up attempts are completed. No further information is expected Information about lot/batch number cannot be obtained; Reported Cause(s) of Death: Death


VAERS ID: 1200438 (history)  
Form: Version 2.0  
Age: 75.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-09
Onset:2021-03-09
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2166 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, COVID-19, Cardiac arrest, Pyrexia
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-09
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ROSUVASTATIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arterial hypertension; Body mass index increased; Dyslipidaemia; Upper respiratory tract infection
Allergies:
Diagnostic Lab Data: Test Date: 20210309; Test Name: Body temperature; Result Unstructured Data: Test Result:39 Centigrade
CDC Split Type: GRPFIZER INC2021384546

Write-up: cardiac arrest; COVID-19 infection; fever (39 degrees Celsius); This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB, regulatory authority number GR-GREOF-20211826. A 75-year-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscularly on 09Mar2021 (Batch/Lot Number: EP2166) at 75-years-old as 0.3 mL, single for COVID-19 immunization. Medical history included chronic dyslipidaemia from an unknown date and unknown if ongoing, unregulated arterial hypertension from an unknown date and unknown if ongoing, very high Body Mass Index (BMI) increased from an unknown date and unknown if ongoing, mild symptoms of infection of the upper respiratory tract from 05Mar2021 to an unknown date. Concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN) taken for dyslipidaemia, start and stop date were not reported. On 09Mar2021, the patient experienced: fever (39 degrees Celsius) (non-serious), cardiac arrest (death, medically significant), COVID-19 infection (death, medically significant), death (as reported) (death, medically significant). The clinical course was reported as follows: According to the reporter, the patient on the day of the vaccination did not report any acute symptoms while he was providing his medical history, neither any allergies. The patient just reported the chronic dyslipidaemia treatment. It was the first dose of the vaccine COMIRNATY and the patient remained in the vaccination center for 15 minutes according to the guidelines; without presenting any symptoms. On 16Mar2021, the patient''s son, called the reporter to declare the death of his father. The patient''s son stated that the patient had a fever the same day of the vaccination and passed away approximately six hours later. A close relative was found positive with SARS-CoV-2 on 13Mar2021; and on the day of the report was still hospitalized. The patient was "buried after the death certificate from a private physician." On 18Mar2021, the patient''s son was contacted, who was also a physician. According to the patient''s son, his father had unregulated arterial hypertension, dyslipidaemia and very high Body Mass Index (BMI) (weighed 110 kilograms for over 40 years with 170 cm height). The patient, four days before his vaccination, had mild symptoms of infection of the upper respiratory tract (mild cough, sniffle and sore throat). On 09Mar2021, the patient was vaccinated and three hours later presented high fever (39 degrees Celsius). The patient three hours later died. The patient''s son stated that the physician who examined his father told him that he found representative data of cardiac arrest and the cause of death was cardiac arrest. Three days later, the patient''s wife was found positive with COVID-19 infection and was hospitalized. According to the patient''s son''s opinion, his father died from COVID-19 infection, even though the patient had not tested positive. The patient underwent lab tests and procedures which included body temperature: 39 Centigrade on 09Mar2021. The clinical outcome of the events: cardiac arrest, COVID-19 infection, death, was fatal. The clinical outcome of the event fever (39 degrees Celsius), was unknown. The patient died on 09Mar2021 due to cardiac arrest, death, COVID-19 infection (according to the patient''s son). It was unknown if an autopsy was performed. The causality assessment from the a regulatory authority for vaccines was unlikely; Method of assessment: a regulatory authority causality criteria. No follow-up attempts are possible. No further information is expected. ; Reported Cause(s) of Death: COVID-19 infection; Cardiac arrest


VAERS ID: 1200557 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-23
Onset:2021-03-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET1831 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Activated partial thromboplastin time, Aspartate aminotransferase, Blood creatine phosphokinase, Blood creatinine, Blood lactic acid, Body temperature, C-reactive protein, International normalised ratio, PCO2, PO2, Platelet count, Procalcitonin, Purpura, Sepsis, Thrombocytopenia, pH body fluid
SMQs:, Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Sepsis (narrow), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-25
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: EUTIROX; BACTRIM; NOVORAPID; DIBASE; TOUJEO; IMBRUVICA; ACICLOVIR; PANTORC
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Autologous bone marrow transplantation therapy; GVHD (chronic cutaneous and intestinal vHD Graft reaction); Hip prosthesis user; Hodgkin''s lymphoma (scleronodular variant); Steroid therapy (Iiatrogenic metabolic decompensation under cortisone therapy)
Allergies:
Diagnostic Lab Data: Test Date: 20210325; Test Name: PTYT; Result Unstructured Data: Test Result: 79; Test Date: 20210325; Test Name: AST; Result Unstructured Data: Test Result:407; Test Date: 20210325; Test Name: CPK; Result Unstructured Data: Test Result:5159; Test Date: 20210325; Test Name: creat; Result Unstructured Data: Test Result:2.15; Test Date: 20210325; Test Name: Lac; Result Unstructured Data: Test Result:8.5; Test Date: 20210324; Test Name: Body temperature; Result Unstructured Data: Test Result:39 Centigrade; Comments: at around 1 pm fever 39 C which drops to 37 C in the afternoon after taking paracetamol 1000 mg; Test Date: 20210324; Test Name: Body temperature; Result Unstructured Data: Test Result:37 Centigrade; Test Date: 20210324; Test Name: Body temperature; Result Unstructured Data: Test Result:38 Centigrade; Comments: At 9 pm T 38 C.; Test Date: 20210325; Test Name: PCR; Result Unstructured Data: Test Result:30.33; Test Date: 20210325; Test Name: INR; Result Unstructured Data: Test Result:2.88; Test Date: 20210325; Test Name: PaCO2; Result Unstructured Data: Test Result:20; Test Date: 20210325; Test Name: pH; Result Unstructured Data: Test Result:7.26; Test Date: 20210325; Test Name: PTLS; Result Unstructured Data: Test Result:41.000; Test Date: 20210325; Test Name: PaO2; Result Unstructured Data: Test Result:236; Test Date: 20210325; Test Name: PCT; Result Unstructured Data: Test Result:62.91
CDC Split Type: ITPFIZER INC2021370951

Write-up: Fever, pain in the upper and lower limbs, swelling, diffuse bluish spots. Diffuse purpura, hypotension, tachycardia, tachypnea; Fever, pain in the upper and lower limbs, swelling, diffuse bluish spots. Diffuse purpura, hypotension, tachycardia, tachypnea; Fever, pain in the upper and lower limbs, swelling, diffuse bluish spots. Diffuse purpura, hypotension, tachycardia, tachypnea; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority (RA), regulatory authority number IT-MINISAL02-706690. A 45-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 23Mar2021 12:32 am (Batch/Lot Number: ET1831) as single dose for Covid-19 immunization. Medical history included Hodgkin''s disease from 01Jan2012 to an unknown date (scleronodular variant), hip prosthesis user from 01Jan2019 to an unknown date, autologous bone marrow transplantation therapy from 01Jan2015 to an unknown date, GVHD (graft versus host disease) chronic cutaneous and intestinal vHD Graft reaction from 01Jan2018 to an unknown date, and corticosteroid therapy (Iiatrogenic metabolic decompensation under cortisone therapy) from an unspecified date. Concomitant medications included levothyroxine sodium (EUTIROX), sulfamethoxazole, trimethoprim (BACTRIM), insulin aspart (NOVORAPID), colecalciferol (DIBASE), insulin glargine (TOUJEO), ibrutinib (IMBRUVICA), aciclovir (ACICLOVIR), and pantoprazole sodium sesquihydrate (PANTORC); all taken for an unspecified indication, start and stop date were not reported. The patient previously had the following vaccines: Vaxigrip Tetra flu vaccine (Oct2020), Boostrix (2019), Imovax polio (2019), Engerix B (2019), ACTHIB (2019), Prevenar 13 (2019), Nimenrix (2019), and Influvac S Tetra (2019); no adverse reactions to vaccines administered. On 23Mar2021 at 12.32 am the 1 dose of vaccine is administered. On 24Mar2021 at around 1 pm, the patient experienced fever 39 C which drops to 37 C in the afternoon after taking paracetamol 1000 mg. At 9 pm, T (temperature) 38 C, taken 1 tablet of Brufen 400 mg. During the night, the patient had pain in the upper and lower limbs, swelling and the appearance of numerous diffuse bluish spots. On 25Mar2021 at 8.21 he arrives at the Emergency Department with presence of diffuse purpura, hypotension, tachycardia, tachypnea. Tests performed on 25Mar2021: EGA, pH (pH body fluid) 7.26, PaO2 236, PaCO2 20, BE-15.4, Lac (Blood lactic acid) 8.5, PTLS (platelet) 41.000; creat (Blood creatinine) 2.15; CPK (Blood creatine phosphokinase) 5159, AST (Aspartate aminotransferase) 407, PCR (C-reactive protein) 30.33, PCT (Procalcitonin) 62.91, INR (International normalised ratio) 2.88, PTYT (partial thromboplastin time) 79. On ultrasound guide positioned cvc in right jugular. On the advice of an infectious specialist, therapy with meropenem 1g, Tigeciclina 100 mg, Ecalta 200 mg. Diagnosis: Sepsis, Thrombocytopenia. At 3.27 pm, she was transferred to the intensive care of Hospital. The patient arrived in the ICU already in cardiorespiratory arrest. The body inspection showed a diffuse and very severe purpura, while the pre-admission course showed the signs and symptoms of an apparent septic shock with an important and irreversible vasoplegic component. Performed cardiopulmonary resuscitation maneuvers found to be in vain. There were no elements of suspicion about serious vaccine reactions. Waiting for information from autopsy results. The clinical picture of rapid onset, its precipitous progression, diffuse skin symptoms, the circulatory structure of progressive and permanent collapse and the Absolute non-responsiveness to drugs are generally suggestive of evolutionary and fatal septic shock, with an irreversible vasoplegic component. Autopsy report is requested again. The patient died on 25Mar2021. An autopsy was performed, and results were not provided. Sender''s comments: 25Mar2021 Local Center of Health Authority: further information and documentation are requested from the reporter and the vaccination service. 26Mar2021 Local Center of Health Authority: Documentation attached to the form is retrieved: Discharge report, photographic documentation, certification of vaccinations performed. 26Mar2021 Local Center of Health Authority: requests for information on follow up and outcome to another health facility. Waiting for an answer 29Mar2021 Local Center of Health Authority: prompt request for information to the Hospital PRIVACY. Waiting for an answer No follow-up attempts are possible. No further information is expected. Information on lot number already obtained.; Sender''s Comments: Based on the available clinical data and in agreement with reporter, event sepsis, purpura and thrombocytopenia with fatal outcome were intercurrent medical conditions not related to vaccine administration. Patient underlying Hodgkin''s disease is considered contributory to the occurrence of events.; Reported Cause(s) of Death: fatal septic shock


VAERS ID: 1200579 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-27
Onset:2021-03-28
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cardiac arrest, Cerebrovascular accident, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-28
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CARDIOASPIRIN; ZYLORIC; FOLIC ACID; CARVEDILOL; LANSOPRAZOLE; LASIX [FUROSEMIDE]; SIDERAL FORTE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Artificial cardiac pacemaker user (The woman had recovered well from the surgery.); Demented (Her medications for the initial form of dementia had been stopped.)
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021370975

Write-up: Sudden death within 24 hours of Comirnaty - Pfizer vaccine booster/cardiac arrest in heart failure in a patient already vasculopathic with dementia and outcome of cerebral stroke; Sudden death within 24 hours of Comirnaty - Pfizer vaccine booster/cardiac arrest in heart failure in a patient already vasculopathic with dementia and outcome of cerebral stroke; Sudden death within 24 hours of Comirnaty - Pfizer vaccine booster/cardiac arrest in heart failure in a patient already vasculopathic with dementia and outcome of cerebral stroke; This is a spontaneous report from a contactable consumer (patient''s daughter) downloaded from a regulatory authority- IT-MINISAL02-708552. An 85-year-old female patient received BNT162B2 (COMIRNATY), dose 2 intramuscular, at age 85 years, on 27Mar2021 09:30 (Batch/Lot Number: ET7205) as 0.3mL, SINGLE DOSE for covid-19 immunisation. Patient''s medical history includes artificial cardiac pacemaker user in 2019 and patient had recovered well from the surgery, and being demented from an unspecified date but her medications for the initial form of dementia had been stopped. Concomitant medications included acetylsalicylic acid (CARDIOASPIRIN), allopurinol (ZYLORIC), folic acid (FOLIC ACID), carvedilol, lansoprazole, furosemide (LASIX) and ascorbic acid, ferric pyrophosphate (SIDERAL FORTE); all taken for an unspecified indication, start and stop date were not reported. Patient historically received first dose of COMIRNATY [BIONTECH MANUFACTURING GMBH (J07BX03) (Batch number: EP9598)] on 06Mar2021 at 09:10 AM for COVID-19 immunisation. On 28Mar2021 09:30, patient had a sudden death within 24 hours of COMIRNATY- Pfizer vaccine booster/cardiac arrest in heart failure in a patient already vasculopathic with dementia and outcome of cerebral stroke. Patient attended a day center. Having heard the attending physician, who claims to have taken note of the statement made by the daughter for the compilation of the Istat certificate as of 31Mar2021 that specified that cause of death cardiac arrest in heart failure in a patient already vasculopathic with dementia and outcome of cerebral stroke. Patient''s daughter stated that death occurred at 09:30 (summer time), about 24 hours after the administration of the 2nd dose of the Pfizer vaccine. The patient died on 28Mar2021. It was not reported if an autopsy was performed. Event assessment: primary source/Comirnaty/ Certain. Sender Comment: Patients with dementia. He attended day center. Having heard the attending physician, who claims to have taken note of the statement made by the daughter for the compilation of the certificate. UPDATE of 31Mar2021: it is specified that on the certificate it was reported as a cause of death cardiac arrest in heart failure in a patient already vasculopathic with dementia and outcome of cerebral stroke Reporter Comment: The report is the daughter - Death occurred at 9.30 (summer time). It should be noted that the death of my mother occurred about 24 hours after the administration of the 2nd dose of the Pfizer vaccine (which took place at about 9.10 on 27Mar2021), as indicated in the same sheet. $g$g Daughter claims that two years ago a pacemaker implant was installed on her mother. The woman had recovered well from the surgery. Her medications for the initial form of dementia had been stopped. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: The report is the daughter - Death occurred at 9.30 (summer time). It should be noted that the death of my mother occurred about 24 hours after the administration of the 2nd dose of the Pfizer vaccine (which took place at about 9.10 on 27Mar2021), as indicated in the same sheet. $g$g Daughter claims that two years ago a pacemaker implant was installed on her mother. The woman had recovered well from the surgery. Her medications for the initial form of dementia had been stopped. ; Reported Cause(s) of Death: Sudden death within 24 hours of Comirnaty - Pfizer vaccine booster/cardiac arrest in heart failure in a patient already vasculopathic with dementia and outcome of cerebral stroke; Sudden death within 24 hours of Comirnaty - Pfizer vaccine booster/car


VAERS ID: 1200600 (history)  
Form: Version 2.0  
Age: 84.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-23
Onset:2021-03-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET3620 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, COVID-19, Diarrhoea, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Pseudomembranous colitis (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Noninfectious diarrhoea (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-28
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NORVASC; PRITORPLUS; LOPRESOR [METOPROLOL TARTRATE]; DIAMICRON; OMNIC; ZYLORIC
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetes mellitus; Hypertension; Hyperuricemia; Ischemic cardiomyopathy; Prostatic hypertrophy (benign)
Allergies:
Diagnostic Lab Data: Test Date: 20210326; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: ITPFIZER INC2021380428

Write-up: drug ineffective/ positive COVID-19 PCR test; drug ineffective/ positive COVID-19 PCR test; asthenia and diarrhea; asthenia and diarrhea; This is a spontaneous report received from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority report number is IT-MINISAL02-709108. An 84-year-old male patient received BNT162B2 (COMIRNATY), on 23Mar2021 at 08:50 (lot number: ET3620; second dose) at 0.3 mL, single in the left arm and on 02Mar2021 (lot number: EP2166; first dose), single dose (as reported); both intramuscularly, for COVID-19 immunization. The patient medical history included hypertension, ischemic cardiomyopathy, diabetes mellitus, prostatic hypertrophy (benign), and hyperuricemia. Concomitant medications included amlodipine besilate (NORVASC, strength: 5 mg) taken for hypertension; hydrochlorothiazide (strength: 80 mg), telmisartan (strength: 12.5 mg) (PRITORPLUS) taken for hypertension; metoprolol tartrate (LOPRESOR [METOPROLOL TARTRATE], strength: 100 mg) taken for ischemic cardiomyopathy; gliclazide (DIAMICRON, strength: 30 mg) taken for diabetes mellitus; tamsulosin hydrochloride (OMNIC, strength: 0.4 mg) taken for prostatic hypertrophy (benign); and allopurinol (ZYLORIC, strength: 300 mg) taken for hyperuricemia. On 23Mar2021, the patient experienced asthenia and diarrhea. On 26Mar2021, the patient experienced drug ineffective/ positive COVID-19 PCR test. The patient died on 28Mar2021 due to the events. It was not reported if an autopsy was performed. Reporter comments: first dose vaccine lot EP2166 administered on 02Mar2021: no adverse reactions. Symptoms appeared a few hours after second vaccination therefore I prescribed the COVID-19 PCR test with a positive outcome on 26Mar2021. From my point of view it is not clinical vaccination failure due to lack of adequate distance from the administration of the second dose or the result. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: first dose vaccine lot EP2166 administered on 02Mar2021: no adverse reactions. Symptoms appeared a few hours after second vaccination therefore I prescribed the COVID-19 PCR test with a positive outcome on 26Mar2021. From my point of view it is not clinical vaccination failure due to lack of adequate distance from the administration of the second dose or the result.; Reported Cause(s) of Death: asthenia and diarrhea; asthenia and diarrhea; drug ineffective/ positive COVID-19 PCR test; drug ineffective/ positive COVID-19 PCR test


VAERS ID: 1200627 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-17
Onset:2021-03-17
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET1831 / 2 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Dysuria, Incorrect route of product administration, Pyrexia, Renal pain
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Drug abuse and dependence (broad), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-31
   Days after onset: 14
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210330; Test Name: Body temperature; Result Unstructured Data: Test Result:high fever of over 39
CDC Split Type: ITPFIZER INC2021380085

Write-up: Severe pain in the kidneys with increasing difficulty in urinating.On 30Mar2021 a high fever of over 39 occurred, which did not go down with antipyretics.On 31Mar2021 he died.Vaccinated with Cominarty; Severe pain in the kidneys with increasing difficulty in urinating.On 30Mar2021 a high fever of over 39 occurred, which did not go down with antipyretics.On 31Mar2021 he died.Vaccinated with Cominarty; Severe pain in the kidneys with increasing difficulty in urinating.On 30Mar2021 a high fever of over 39 occurred, which did not go down with antipyretics.On 31Mar2021 he died.Vaccinated with Cominarty; COMIRNATY cutaneous; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority, regulatory authority number: IT-MINISAL02-709680. A 90-year-old male patient received second dose of bnt162b2 (COMIRNATY), cutaneous, administered in Arm Right (right shoulder) on 17Mar2021 (Lot Number: ET1831) as a single dose (1 DF) for covid-19 immunisation. Medical history was not reported. Other products used (treatments based on supplements, medicinal plants or homeopathic substances): none. Patient received first dose of bnt162b2 (COMIRNATY) on 21Feb2021 for covid-19 immunisation. On 28Mar2021 patient experienced severe pain in the kidneys with increasing difficulty in urinating, on 30Mar2021 a high fever of over 39 occurred, which did not go down with antipyretics. On 31Mar2021 patient died due to severe pain in the kidneys with increasing difficulty in urinating and high fever. Vaccinated with Comirnaty. It was not reported if an autopsy was performed. It was reported that on 01Apr2021 was contacted the reporter to ask him to specify the batch of vaccine administered and other documentation useful for the evaluation of the case. Unfortunately it was not possible to do anything other than declare the death. Impact on quality of life (10/10). Reporter''s comment: cancer. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Kidney pain; Urination difficulty; Fever


VAERS ID: 1200635 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-20
Onset:2021-03-25
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET3620-12-041 / 2 RA / OT

Administered by: Other       Purchased by: ?
Symptoms: Acute coronary syndrome
SMQs:, Myocardial infarction (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-25
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021380042

Write-up: Acute coronary syndrome; This is a spontaneous report downloaded from the regulatory authority (Regulatory Authority report number: IT-MINISAL02-709770). A contactable physician (contactable through Regulatory Authority only) reported that a 97-year-old female patient received the second dose of BNT162B2 (COMIRNATY, Lot number: ET3620-12-041; Expiration date was not reported), intramuscularly on the right arm on 20Mar2021 (14:23) as a single dose, for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (COMIRNATY, Lot number and expiration date were not reported) on an unspecified date for COVID-19 immunization. On 25Mar2021, the patient had acute coronary syndrome. The patient was not a heart patient and had no major medical conditions. The patient had died on 25Mar2021 due to acute coronary syndrome. It was unknown if an autopsy was performed. No follow-up attempts are possible. No further information is expected. Lot number was already provided.; Reporter''s Comments: The patient was given the second dose of Comirnaty Vaccine on 20Mar2021. On 25Mar2021 she died of acute coronary syndrome. the patient was not a heart patient and had no major medical conditions.; Reported Cause(s) of Death: acute coronary syndrome


Result pages: prev   1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1267&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166